Graves' disease
RecruitingLong-Term Study of Imeroprubart in Adults With Graves' Disease
- Disease:Graves' disease
- Substances:IMEROPRUBART
Belgium- Participants:18–64 years · 65+ years
- Substances:IMEROPRUBART
- Sponsor:Immunovant Sciences GmbH
Rare diseases
Investigational molecules
Locations

Viaduktstrasse 8, 4051
Immunovant Sciences GmbH funds clinical research in Graves’ disease, thyroid eye disease, and related thyroid hormone dysregulation, with attention to endocrine and orbital manifestations.
Its research activity also extends to maintaining euthyroidism and evaluating outcomes tied to antithyroid therapy.
Immunovant Sciences GmbH runs clinical trials in conditions such as Graves' disease, Chronic inflammatory demyelinating polyradiculoneuropathy, Endocrine ophthalmopathy, Myasthenia gravis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
Austria
Bulgaria
Czechia
Belgium
Germany
Bulgaria
Bulgaria
Belgium
Germany
Belgium
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.